Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) Comparison with companies in other sectors?

Recordati Industria Chimica e Farmaceutica S.p.A. has a share price of 205.56M. You can analyze Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) competitors across different market sectors through stock heatmaps.

What are RCDTF's NET and operating margins?

Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) operating margin is around 0.27, and net profit margin is approximately 0.17 as of the latest reports.

In what way does RCDTF's earnings per share (EPS) trend reflect its financial momentum?

Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) EPS is 2.22 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Recordati Industria Chimica e Farmaceutica S.p.A. is 29.48, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Recordati Industria Chimica e Farmaceutica S.p.A.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Recordati Industria Chimica e Farmaceutica S.p.A. like P/E which is 20.91, P/B which is 4.42, and PEG which is 48.87. Compare them with sector averages to evaluate if the stock is priced fairly.

Recordati Industria Chimica e Farmaceutica S.p.A.

RCDTF•PNK

Healthcare

Drug Manufacturers - General

$65.44

$0.00(0.00%)

Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$2.22

P/E Ratio

29.48

ROE

0.22%

Net Margin

0.17%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$13.45B

Shares OutstandingTotal number of shares issued

$205.56M

Book Value/ShareNet worth per share

$9.58

Revenue/ShareAnnual revenue per share

$11.70

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$2.22

Net MarginNet income as percentage of revenue

17.32%

Operating MarginOperating income as percentage of revenue

26.84%

ROEReturn on shareholders' equity

22.19%

ROAReturn on total assets

8.09%

ROCEReturn on capital employed

15.50%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-1.29

Cash/ShareCash and equivalents per share

$1.61

FCF YieldFree cash flow as percentage of market cap

-3.06%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$1.23

Dividend YieldAnnual dividend as percentage of stock price

2.90%

Financial Ratios Analysis data is not available for RCDTFFinancial Ratios Analysis details for RCDTF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for RCDTFSector Benchmarking details for RCDTF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Recordati Industria Chimica e Farmaceutica S.p.A. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Recordati Industria Chimica e Farmaceutica S.p.A.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Recordati Industria Chimica e Farmaceutica S.p.A.'s unique business strengths and challenges.

Key Financial Metrics for Recordati Industria Chimica e Farmaceutica S.p.A.

For Recordati Industria Chimica e Farmaceutica S.p.A., essential financial indicators include EPS 2.22, PE 29.48, and ROE 0.22. These key ratios reveal insights into Recordati Industria Chimica e Farmaceutica S.p.A.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Recordati Industria Chimica e Farmaceutica S.p.A. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Recordati Industria Chimica e Farmaceutica S.p.A.

Metrics like Net Margin 17.32% and ROA 8.09% shed light on how well Recordati Industria Chimica e Farmaceutica S.p.A. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Recordati Industria Chimica e Farmaceutica S.p.A. can sustain its operations and continue growing in the future.

Valuation and Market Position of Recordati Industria Chimica e Farmaceutica S.p.A.

Using ratios such as P/B Ratio 4.42 and PEG Ratio 48.87, investors can assess whether Recordati Industria Chimica e Farmaceutica S.p.A. is appropriately valued based on its financials and growth potential. These figures, combined with Recordati Industria Chimica e Farmaceutica S.p.A.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Recordati Industria Chimica e Farmaceutica S.p.A.

Financial health indicators, such as Debt/Equity Ratio 0.01 and Cash Flow $-1.29, provide a snapshot of Recordati Industria Chimica e Farmaceutica S.p.A.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Recordati Industria Chimica e Farmaceutica S.p.A., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Recordati Industria Chimica e Farmaceutica S.p.A.

Investing in Recordati Industria Chimica e Farmaceutica S.p.A. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Recordati Industria Chimica e Farmaceutica S.p.A. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;